Photodynamic Therapy of Ocular Diseases

Authors:

Brand: Lippincott Williams & Wilkins

ISBN: 9780781734462

504.00 zł

453.60 zł Save 50.40 zł Tax included

Lowest price within 30 days before promotion: 453.60 zł

Quantity

Product unavailable

Out of print

Notify me about new stock Enter your email address to get notifications about new stock of this product

Delivery policy

Choose Paczkomat Inpost, Orlen Paczka, DPD or Poczta Polska. Click for more details

Security policy

Pay with a quick bank transfer, payment card or cash on delivery. Click for more details

Return policy

If you are a consumer, you can return the goods within 14 days. Click for more details

Description

This unique text, authored by the individuals who pioneered the use of Photodynamic Therapy (PDT), is designed to provide clinicians with an understanding of the basic physics of PDT and the rationale and techniques of PDT in ophthalmology and especially in age-related macular degeneration. The different photosensitizers, lasers, and possible future use of this new therapeutic modality for other intraocular pathologies are also discussed. This text offers a step-by-step, detailed approach to the use of PDT, picking up where the scientific journal articles leave off.

Product Details

Brand Lippincott Williams & Wilkins

Reference 38581

EAN13 9780781734462

ISBN 9780781734462

Data sheet

Publication date: 2003
Issue number: 1
Cover: hard cover
Pages count: 309
Dimensions (mm): 216 x 279
Weight (g): 1048

SECTION I:: INTRODUCTION TO PHOTODYNAMIC THERAPY 1
History of Photodynamic Therapy for Ocular Disorders 1
Joan W. Miller and Evangelos S. Gragoudas
Principles of Photodynamic Therapy 11
Hubert Erik van den Bergh and J.P. Ballini
SECTION II:: PRECLINICAL STUDIES 43
In Vitro Assessment and Bioassay of Photosensitizers for Ocular Photodynamic Therapy 43
Reem Z. Renno, Yoshiko Terada, Evangelos S. Gragoudas, and Joan W. Miller
Combination of Photodynamic Therapy and Antiangiogenic Agents 53
Reem Z. Renno, Yoshiko Terada, Evangelos S. Gragoudas, and Joan W. Miller
Verteporfin PDT for Experimental Choroidal Neovascularization 63
Joan W. Miller and Evangelos S. Gragoudas
Photodynamic Therapy for Experimental Choroidal Neovascularization Using ATX-S10(Na) 73
Akira Obana
Photodynamic Therapy for Experimental Choroidal Neovascularization Using Purlytin 85
Darius M. Moshfeghi and Gholam A. Peyman
Photodynamic Therapy for Experimental Choroidal Neovascularization Using Lu-Tex 89
J. Daniel Arbour and Danny Gauthier
Photodynamic Therapy for Iris Neovascularization 99
Deeba Husain, Joan W. Miller, and Evangelos S. Gragoudas
Recovery After Repeated Photodynamic Therapy Treatments for Normal Retina and Choroid 107
Martin H. Reinke, Evangelos S. Gragoudas, and Joan W. Miller
The Ocular Localization of Photosensitizers 119
Sean Koh and Robert Haimovici
Photodynamic Therapy of Experimental Choroidal Neovascularization Using NPe6 129
Shin Yoneya, Darius M. Moshfeghi, and Gholam A. Peyman
Photodynamic Therapy for Experimental Intraocular Tumors 135
Rosa Y. Kim and Lucy H. Y. Young
SECTION III:: CLINICAL STUDIES 139
Verteporfin Photodynamic Therapy for Age- Related Macular Degeneration 139
Part 1. Verteporfin Photodynamic Therapy for Age-Related Macular Degeneration:: How To Do It 139
René-Pierre Copt and Leonidas Zografos
Part 2. Fluorescein Angiography and Optical Coherence Tomography in Photodynamic Therapy for Choroidal Neovascularization Caused by Age-Related Macular Degeneration 143
Gisèle Soubrane and Gabriel Coscas
Part 3. Indocyanine Green Angiography in Photodynamic Therapy of Choroidal Neovascularization 156
Antonio P. Ciardella, Jason S. Slakter, and Lawrence A. Yannuzzi
Part 4. Subfoveal Choroidal Blood Flow and Its Regulation After Verteporfin Photodynamic Therapy in Choroidal Neovascularization 164
Constantin J. Pournaras, Charles E. Riva, Eric Logean, and Gisèle Soubrane
Part 5. Results of Age-Related Macular Degeneration Trials Using Verteporfin PDT:: Phases I and II 172
Joan W. Miller and Evangelos S. Gragoudas
Part 6. Results of Age-Related Macular Degeneration Trials Using Verteporfin PDT (Visudyne):: the Treatment of Age- Related Macular Degeneration with Photodynamic Therapy and Verteporfin in Photodynamic Therapy Trials 181
Jennifer Joan Arnold
Verteporfin Photodynamic Therapy in Pathologic Myopia 197
Jordi M. Monés